TIPANAT 20MG/8.19MG TABLET
Form: Tablets
Pack Size: 20 TABLETS
Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)
MRP: ₹8837.68
NATCO PHARMA LTD (ONCOLOGY DIV): Tipanat 20MG/8.19MG Tablet, 20 tablets, salt trifluridine + tipiracil 20mg/8.19mg. NPPA has revised its MRP from Rs 9,375 to Rs 8,837.68 (6% lower) with effect from 09-11-2026; trade rate Rs 6,733.47. Group: oral antimetabolite chemotherapy. No other manufacturer of this salt and strength is listed here yet. Handling/counselling: take within an hour after breakfast and dinner; cytotoxic: handle and dispose of as hazardous waste. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.